Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response.
Nakajima
H
H
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Oka
T
T
D000818:Animals; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D017931:DNA Primers; D053222:Fas Ligand Protein; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007939:Leukemia L1210; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000502:physiology*; D051379:Mice; D016853:Muromonab-CD3; D011090:Polyenes / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000096:biosynthesis / Q000502:physiology*
D017931:DNA Primers; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D016853:Muromonab-CD3; D011090:Polyenes; D019014:fas Receptor; D016572:Cyclosporine; D013755:Tetradecanoylphorbol Acetate; D020123:Sirolimus; D016559:Tacrolimus